These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11240582)

  • 1. Naltrexone as a treatment of self-injurious behavior--a case report.
    Griengl H; Sendera A; Dantendorfer K
    Acta Psychiatr Scand; 2001 Mar; 103(3):234-6. PubMed ID: 11240582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities.
    Rana F; Gormez A; Varghese S
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009084. PubMed ID: 23633366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
    Roth AS; Ostroff RB; Hoffman RE
    J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of naltrexone on self-injurious behavior.
    Sandman CA; Hetrick W; Taylor DV; Marion SD; Touchette P; Barron JL; Martinezzi V; Steinberg RM; Crinella FM
    Am J Ment Retard; 2000 Mar; 105(2):103-17. PubMed ID: 10755174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone and self-injurious behavior: a retrospective population study.
    Casner JA; Weinheimer B; Gualtieri CT
    J Clin Psychopharmacol; 1996 Oct; 16(5):389-94. PubMed ID: 8889912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone treatment of dementia with severe self-injurious behaviors: a single case study.
    Vance HB; Kauffmann C; Pumariega AJ; Del Mundo A
    Psychiatry; 2000; 63(3):288-99. PubMed ID: 11125673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone as a treatment of self-injurious behavior: a case report.
    Griengl H; Dantendorfer K
    Eur Psychiatry; 2001 Apr; 16(3):193-4. PubMed ID: 11353600
    [No Abstract]   [Full Text] [Related]  

  • 8. Using analog baselines to assess the effects of naltrexone on self-injurious behavior.
    Garcia D; Smith RG
    Res Dev Disabil; 1999; 20(1):1-21. PubMed ID: 9987807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone treatment of self-injurious behavior.
    Godart NT; Agman G; Perdereau F; Jeammet P
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1076-8. PubMed ID: 10986803
    [No Abstract]   [Full Text] [Related]  

  • 10. Naltrexone treatment for a 3-year-old boy with self-injurious behavior.
    White T; Schultz SK
    Am J Psychiatry; 2000 Oct; 157(10):1574-82. PubMed ID: 11007709
    [No Abstract]   [Full Text] [Related]  

  • 11. Dissociation of POMC peptides after self-injury predicts responses to centrally acting opiate blockers.
    Sandman CA; Hetrick W; Taylor DV; Chicz-DeMet A
    Am J Ment Retard; 1997 Sep; 102(2):182-99. PubMed ID: 9327093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.
    Willemsen-Swinkels SH; Buitelaar JK; Nijhof GJ; van England H
    Arch Gen Psychiatry; 1995 Sep; 52(9):766-73. PubMed ID: 7654128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical uses of naltrexone: a review of the evidence.
    Modesto-Lowe V; Van Kirk J
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cessation of long-term naltrexone administration: longitudinal follow-ups.
    Crews WD; Rhodes RD; Bonaventura SH; Rowe FB; Goering AM
    Res Dev Disabil; 1999; 20(1):23-30. PubMed ID: 9987808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Naltrexone in the treatment of dissociative disorders--reflections with regard to a comprehensive therapeutic concept of borderline disorders].
    Bolm T; Piegler T
    Psychiatr Prax; 2001 Jul; 28(5):214-8. PubMed ID: 11479827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of dissociative symptoms in borderline personality disorder with naltrexone: supplementary comments].
    Schmahl C; Bohus M
    Nervenarzt; 2000 May; 71(5):427. PubMed ID: 10846724
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of opiate antagonists for recurrent self-injurious behavior.
    Buzan RD; Thomas M; Dubovsky SL; Treadway J
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):437-44. PubMed ID: 8555746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary study of altered skin temperature at body sites associated with self-injurious behavior in adults who have developmental disabilities.
    Symons FJ; Sutton KA; Bodfish JW
    Am J Ment Retard; 2001 Jul; 106(4):336-43. PubMed ID: 11414874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
    Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
    Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case study: paradoxical response to naltrexone treatment of self-injurious behavior.
    Benjamin S; Seek A; Tresise L; Price E; Gagnon M
    J Am Acad Child Adolesc Psychiatry; 1995 Feb; 34(2):238-42. PubMed ID: 7896657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.